Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCirata Regulatory News (CRTA)

Share Price Information for Cirata (CRTA)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.00
Ask:
17.95
Spread: 0.95 (5.588%)
Market Cap: £22.12m
CRTA Live PriceLast checked at - London Stock Exchange

Intraday Cirata Share Chart

Director/PDMR Shareholding

7 Dec 2023 07:00

RNS Number : 9382V
Cirata PLC
07 December 2023
 

7 December 2023

 

Cirata plc

("Cirata" or the "Company")

Director/PDMR Shareholdings

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

 

Cirata plc (LSE: CRTA) provides the following notification of a share transfer and a share purchase by persons discharging managerial responsibilities ("PDMR").

 

On 4 December 2023, Mr Stephen Kelly, Chief Executive Officer, transferred 82,000 Ordinary Shares in Cirata to each of his daughters Hannah, Isabel and Naomi Kelly (an aggregate total of 246,000 Ordinary Shares (the "Share Transfers").

 

Separately on 4 December 2023, Mr Stephen Kelly, purchased 15,980 Ordinary Shares in Cirata at a price of 63 pence per Ordinary Share (the "Share Purchase").

 

Following the completion of the Share Purchase, the Share Transfer and once the previously announced Allotment Award[1] share matching transaction has been completed, Mr Stephen Kelly will be the beneficial owner of 1,802,660 Ordinary Shares, representing approximately 1.56% of the Company's "total issued" share capital[2].

 

The following represents the PDMR's beneficial interest post completion of the Share Purchase, the Share transfers and the "Allotment Award".

 

Transaction

Shares / %

Total beneficial interest as of COB 3 December 2023

1,182,680

Number of Ordinary Shares acquired pursuant to the Share Purchase on 4 December 2023

15,980

Total beneficial interest post completion of the Share Purchase on 4 December 2023

1,198,660

Less the transfer of Ordinary Shares on 4 December 2023, 

the "Share Transfers"

246,000

Ordinary Shares acquired pursuant to the Allotment Award

850,000

Total beneficial Interest post completion of Share Transfers, Share Purchase & Allotment Award

1,802,660

Total beneficial interest as a percentage of the Company's total issued share capital following the Allotment of the Award

1.56%

 

The Notification of Dealing Form for the transfer and purchase of Ordinary Shares is included at the end of this announcement.

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

This announcement contains information that qualifies or may qualify as inside information. The person responsible for arranging the release of this announcement on behalf of Cirata plc is Larry Webster, Company Secretary.

 

Cirata plc

Via FTI Consulting

Stephen Kelly, Chief Executive Officer

Ijoma Maluza, Chief Financial Officer

Daniel Hayes, Investor Relations

FTI Consulting

+44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali

 

Stifel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Richard Short / Tom Marsh

 

Liberum (Joint Broker)

 

+44 (0)20 3100 2000

Max Jones / Ben Cryer / Miquela Bezuidenhoudt

 

 

 

 

 

 

About Cirata

 

Cirata accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Stephen Kelly

 

2

 

Reason for the notification

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Cirata plc

b)

LEI

213800Y1A75RSC698O04

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares 10 p each

 

 

ISIN: JE00B6Y3DV84

b)

 

Nature of the transaction

 

Purchase of Ordinary Shares

 

 

c)

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

63 pence

15,980

d)

 

Aggregated information

- Aggregated volume

- Price

 

15,980

 

63 pence

e)

 

Date of the transaction

04 December 2023

f)

Place of the transaction

London Stock Exchange (AIMX)

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

Stephen Kelly

 

2

 

Reason for the notification

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Cirata plc

b)

LEI

213800Y1A75RSC698O04

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Transfer of Ordinary Shares 10p each

 

 

ISIN: JE00B6Y3DV84

b)

 

Nature of the transaction

 

Transfer of ordinary shares

 

 

c)

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

Nil

82,000

Nil

82,000

Nil

82,000

d)

 

Aggregated information

- Aggregated volume

- Price

 

246,000

 

Nil

e)

 

Date of the transaction

4 December 2023

f)

Place of the transaction

London Stock Exchange (AIMX)

 

 

 

 


[1]As described in our 17 November 2023 regulatory announcement, under the terms of the Allotment Award share matching transaction Mr Kelly will be allocated a total of 850,000 ordinary shares. These shares will be issued by 31 December 2023.

[2] The Company's issued share capital at 1 December 2023 consisted of 114,933,711 ordinary shares of ten pence each with voting rights admitted to trading. The Company holds no ordinary shares in Treasury. Upon completion of the Allotment Share Awards the issued share capital will increase by 850,000 shares leading to a total of 115,783,648 issued share capital.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBRBDDSXGDGXL
Date   Source Headline
1st Jun 20267:00 amRNSBlock Listing Return
20th May 20267:00 amRNSResult of AGM
5th May 20267:00 amRNSHolding(s) in Company
23rd Apr 20268:52 amRNSAmendment to Notice of Annual General Meeting
21st Apr 20267:00 amRNSGrant of Awards & PDMR Dealing
14th Apr 20267:00 amRNSTrading Statement
31st Mar 20263:39 pmRNSManagement Changes
31st Mar 20267:00 amRNSPreliminary Results
4th Feb 20268:54 amRNSGrant of Awards & PDMR Dealing
14th Jan 20267:00 amRNSQ4 FY25 Trading Update
19th Dec 20252:50 pmRNSDevOps Final Consideration Received
19th Dec 20252:50 pmRNSDevOps Final Consideration Received
1st Dec 20259:35 amRNSBlock Listing Return
27th Nov 20257:00 amRNSFinancial Conduct Authority Update
17th Nov 20257:00 amRNS$6.7m Multiyear Contract win
27th Oct 202510:05 amRNSNotification of Major Holdings
16th Oct 20257:00 amRNSTrading Statement
13th Oct 20257:00 amRNS$3.1m Multiyear Contract with leading US Insurer
12th Sep 202511:02 amRNSGrant of Awards & PDMR Dealing
10th Sep 20257:00 amRNSNotification of Major Holdings
9th Sep 20258:00 amRNS-RCirata launches new data platform
3rd Sep 20257:00 amRNSInterim results
13th Aug 20257:00 amRNSGrant of Share Options to PDMRs
11th Aug 20257:00 amRNSCompletion of DevOps Divestment
15th Jul 20257:07 amRNSQ2 and H1FY25 Trading Update
30th Jun 20257:01 amRNSHolding(s) in Company
30th Jun 20257:00 amRNS$700K Multiyear Data Integration Contract Renewal
10th Jun 20257:00 amRNSBoard Appointment
3rd Jun 20252:39 pmRNSBlock Listing Return
8th May 20254:47 pmRNSResult of AGM
29th Apr 202511:44 amRNSGrant of Share Options to PDMRs
16th Apr 20257:00 amRNSQ1FY25 Trading Statement
8th Apr 20257:00 amRNSAnnual Report & Notice of AGM
2nd Apr 20253:51 pmRNSNotification of Major Holdings
31st Mar 20257:01 amRNSContract win
31st Mar 20257:00 amRNSPreliminary Results
27th Feb 20257:00 amRNSNew logo in Telecom sector
20th Feb 20257:00 amRNSTotal Voting Rights
20th Jan 20256:29 pmRNSPDMR dealings and Total Voting Rights
9th Jan 20257:00 amRNSQ4FY24 Trading Update
16th Dec 20247:00 amRNSContract Win and FY24 Guidance
13th Dec 20243:46 pmRNSVesting of Restricted Stock & Director Dealings
11th Dec 20247:00 amRNSIssue of Equity
9th Dec 20247:00 amRNSMarvell Contract Renewal
2nd Dec 20243:40 pmRNSBlock Listing Return
1st Nov 20247:00 amRNSGrant of Share Options to PDMRs
24th Oct 20247:00 amRNSPDMR Transactions
9th Oct 20247:00 amRNSQ3 Trading Update and Outlook
2nd Oct 20243:19 pmRNSAmendment of OEM sales partnership with IBM
1st Oct 20247:00 amRNSBoard Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.